Codexis, Inc.
CDXSNASDAQHealthcare● Active
$2.61
+$0.05(+1.76%)
Market Cap$236785557
P/E Ratio—
52W High$3.87
52W Low$0.96
Codexis, Inc. (CDXS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDXS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.10
Est. -$0.11 · +9.1%
Revenue
$0.02B
Est. $0.01B · +5.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
CDXS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.17 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.11 | -$0.10 | +9.1% | $0.02B | $0.01B | +5.0% |
| ▲ Q1 FY2026 | Mar 11, 2026 | $0.01 | $0.11 | +1000.0% | $0.04B | $0.04B | +8.6% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.15 | -$0.22 | -46.7% | $0.01B | $0.04B | -76.0% |
| ▲ Q3 FY2025 | Aug 13, 2025 | -$0.17 | -$0.16 | +5.9% | $0.02B | $0.02B | -21.3% |
| ▼ Q2 FY2025 | May 14, 2025 | -$0.20 | -$0.25 | -25.0% | $0.01B | $0.01B | -21.9% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -$0.04 | -$0.13 | -225.0% | $0.02B | $0.03B | -21.7% |
| ▼ Q4 FY2024 | Oct 31, 2024 | -$0.25 | -$0.29 | -16.0% | $0.01B | $0.03B | -53.2% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.17
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.10
EPS Est.
-$0.11
EPS Surpr.
+9.1%
Revenue
$0.02B
Q1 FY2026
Mar 11, 2026Beat
EPS Actual
$0.11
EPS Est.
$0.01
EPS Surpr.
+1000.0%
Revenue
$0.04B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.22
EPS Est.
-$0.15
EPS Surpr.
-46.7%
Revenue
$0.01B
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.17
EPS Surpr.
+5.9%
Revenue
$0.02B
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$0.25
EPS Est.
-$0.20
EPS Surpr.
-25.0%
Revenue
$0.01B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$0.13
EPS Est.
-$0.04
EPS Surpr.
-225.0%
Revenue
$0.02B
Q4 FY2024
Oct 31, 2024Miss
EPS Actual
-$0.29
EPS Est.
-$0.25
EPS Surpr.
-16.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.03 | $-0.03 | $-0.02 | 1 |
| Q3 FY2027 | $-0.07 | $-0.06 | $-0.05 | 1 |
| Q2 FY2027 | $-0.10 | $-0.09 | $-0.08 | 1 |
| Q1 FY2027 | $-0.11 | $-0.10 | $-0.08 | 1 |
| Q4 FY2026 | $-0.07 | $-0.06 | $-0.05 | 1 |
| Q3 FY2026 | $-0.11 | $-0.10 | $-0.08 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +9.1% | $2.66 | $2.58 | -3.01% |
| ▲ Q1 FY2026 | Mar 11, 2026 | +1000.0% | $1.24 | $1.27 | +2.42% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -46.7% | $2.15 | $2.04 | -5.12% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +5.9% | $2.86 | $3.05 | +6.64% |
| ▼ Q2 FY2025 | May 14, 2025 | -25.0% | $2.56 | $2.47 | -3.52% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -225.0% | $4.16 | $3.93 | -5.53% |
| ▼ Q4 FY2024 | Oct 31, 2024 | -16.0% | $3.21 | $3.14 | -2.18% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -23.1% | $3.02 | $3.15 | +4.30% |
Q2 FY2026-3.01%
Report Date
May 7, 2026
EPS Beat/Miss
+9.1%
Price Before
$2.66
Price After
$2.58
Q1 FY2026+2.42%
Report Date
Mar 11, 2026
EPS Beat/Miss
+1000.0%
Price Before
$1.24
Price After
$1.27
Q4 FY2025-5.12%
Report Date
Nov 6, 2025
EPS Beat/Miss
-46.7%
Price Before
$2.15
Price After
$2.04
Q3 FY2025+6.64%
Report Date
Aug 13, 2025
EPS Beat/Miss
+5.9%
Price Before
$2.86
Price After
$3.05
Q2 FY2025-3.52%
Report Date
May 14, 2025
EPS Beat/Miss
-25.0%
Price Before
$2.56
Price After
$2.47
Q1 FY2025-5.53%
Report Date
Feb 27, 2025
EPS Beat/Miss
-225.0%
Price Before
$4.16
Price After
$3.93
Q4 FY2024-2.18%
Report Date
Oct 31, 2024
EPS Beat/Miss
-16.0%
Price Before
$3.21
Price After
$3.14
Q3 FY2024+4.30%
Report Date
Aug 8, 2024
EPS Beat/Miss
-23.1%
Price Before
$3.02
Price After
$3.15
Avg Beat Reaction+2.02%
Avg Miss Reaction-2.41%
Beat Rate3 / 8 quarters
Largest Move+6.64% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDXS ends December
Codexis, Inc. (CDXS) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.10 — beating the analyst consensus of $-0.11 by +9.1%. CDXS has beaten EPS estimates for 2 consecutive quarters. The next CDXS earnings date is expected around September 1, 2026.
Each quarter, investors track CDXS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDXS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDXS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDXS earnings · 5 questionsCodexis, Inc.'s next earnings report is expected around September 1, 2026. CDXS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDXS historically reports after market close (AMC).
CDXS earnings datewhen is CDXS earningsCDXS next earnings datewhen does CDXS report earningsCDXS earnings calendar
▸ Source: FMP · Codexis, Inc. SEC filings · US GAAP · Codexis, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026